ZS to acquire Trials.ai!
Our Smart Protocol system aims to automate and add intelligence to clinical trial design with AI
WHY WE DO IT
Because patients don’t have time to wait!
Our Smart Protocol solution is revolutionizing the manual way research teams design clinical trials.
In the digital age, humans cannot physically read and digest every bit of information relevant to a given decision. In addition, almost every company has valuable data that is not being used - more often than not, documents are living in repositories with no line of sight. As a result, companies life science companies are making important and costly decisions with incomplete information. We aim to take companies like yours from a document-driven environment into a data-driven one.
We are reimagining how clinical trials are researched and planned by removing the barriers between data and end-users. We do this by mining massive amounts of trial-related documents from both customers and the public domain— so you don’t have to. Those data then become the foundation for machine learning insights and recommendations.
Our goal is to get treatments to patients, faster.
HOW WE DO IT
Big data for better decisions
The Trials.ai platform leverages state of the art, artificial intelligence by way of NLP and ML to optimize clinical trial protocols for speed and efficiencies.
Our algorithms mine massive amounts of trial-related documents.
Clinical Trials Ontology
Targeted training and tuning with our ontology allows for greater precision.
Smart Protocol Design & Authoring
We see a world where optimized protocols as data feed downstream documents and systems to speed study startup and decrease manual inputs and errors. Below are just a few things we're currently focusing on at Trials AI:
- Objectives & Endpoints
- Inclusion / Exclusion
- Study design
- Outcome measurements
- Regulatory guidances
- Schedule of assessments
- Connect to downstream systems and speed study startup
- Access the latest literature at your fingertips
- Unique ML algorithms to flag potential threats
Across All Therapeutic Areas
The system cross-compares data across all therapeutic areas from past trials, medical journals, thought-leader articles, clinical, regulatory agencies and other trial-related documents to find similarities, provide recommendations and surface contextual points of interest.
HOW WE DO IT
Optimize for Time, Cost, Risk, and Patient Centricity
Think of Trials.ai as the best second opinion you’ve ever had. The result is an optimized trial that ultimately enables a new treatment to reach patients faster— all through the lens of time, cost, and patient-centricity. Algorithms under development include a focus on amendments, trial complexity, and patient burden.
Our system also looks for potential pitfalls that might need to be flagged and adjusted. Get feedback about how each decision you make affects: